Evidence map›Paper›PMID 17981733›Full record

ReviewFrontiers in bioscience : a journal and virtual library2008

Protein interactions and complexes in human microRNA biogenesis and function.

Marjorie P Perron, Patrick Provost

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in bioscience : a journal and virtual library, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. miRNA-Based Technologies in Cancer Therapy.Journal of personalized medicine · 2023
    Review
  9. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?International journal of molecular sciences · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Regulation of MicroRNAs.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marjorie P PerronCentre de Recherche du CHUL-CHUQ, 2705 Blvd Laurier, Quebec, QC, G1V 4G2, Canada.
Patrick Provost
Centre hospitalier universitaire de Québec · CA

Funding

CIHR 69151
6 · The paper itself

Abstract

Encoded in the genome of most eukaryotes, microRNAs (miRNAs) have been proposed to regulate specifically up to 90% of human genes through a process known as miRNA-guided RNA silencing. The aim of this review is to present this process as the integration of a succession of specialized molecular machines exerting well defined functions. The nuclear microprocessor complex initially recognizes and processes its primary miRNA substrate into a miRNA precursor (pre-miRNA). This structure is then exported to the cytoplasm by the Exportin-5 complex where it is presented to the pre-miRNA processing complex. Following pre-miRNA conversion into a miRNA:miRNA* duplex, this complex is assembled into a miRNA-containing ribonucleoprotein (miRNP) complex, after which the miRNA strand is selected. The degree of complementarity of the miRNA for its messenger RNA (mRNA) target guides the recruitment of the miRNP complex. Initially repressing its translation, the miRNP-silenced mRNA is directed to the P-bodies, where the mRNA is either released from its inhibition upon a cellular signal and/or actively degraded. The potency and specificity of miRNA biogenesis and function rely on the distinct protein x protein, protein x RNA and RNA:RNA interactions found in different complexes, each of which fulfill a specific function in a well orchestrated process.

Indexed as

AnimalsArgonaute ProteinsDiGeorge SyndromeEukaryotic Initiation Factor-2Gene SilencingHumansKaryopherinsMicroRNAsModels, BiologicalProtein Interaction MappingProteinsRibonuclease IIIRNA-Binding ProteinsRNA, Small InterferingTrans-Activation Responsive RNA-Binding ProteinAGO2 protein, humanArgonaute ProteinsEukaryotic Initiation Factor-2KaryopherinsMicroRNAsProteinsRibonuclease IIIRNA-Binding ProteinsRNA, Small InterferingTrans-Activation Responsive RNA-Binding ProteinXPO5 protein, human

Identifiers

PMID17981733
PMCPMC2901379
OpenAlexW62946089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.